NP / PA
Echeverria, Analisa
Echeverria, Analisa was paid $78K by Medicaid between Oct 2022 and Mar 2023, across 21 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 33% of everything it billed.
33Billing provider infoECHEVERRIA, ANALISA
EVERETT, MA 02149
EVERETT, MA 02149
33aNPI1285181925assigned 09/09/2016
33bProvider typePediatric Nurse Practitioner
28Total paid$78K
24GClaims2,000
24DCodes billed21
24AFirst – last monthOct 2022 – Mar 2023
Compared with peers
Next to other Pediatric Nurse Practitioner providers in Massachusetts
Rank by total paid#17 of 125
Median peer was paid$6K
This provider vs. median13×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 980 | $41K | |
| 2023 | 1,020 | $37K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 33% | 457 | 427 | $26K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 20% | 160 | 149 | $16K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 9.7% | 90 | 90 | $8K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 7.6% | 116 | 115 | $6K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 6.6% | 140 | 135 | $5K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3.8% | 127 | 125 | $3K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3.2% | 80 | 80 | $2K |
| 92587 | 3.1% | 140 | 139 | $2K | |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 2.5% | 218 | 217 | $2K |
| 90461 | 2.4% | 71 | 70 | $2K | |
| 96127 | 1.9% | 146 | 146 | $1K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.3% | 12 | 12 | $997.80 |
9 more codes
| 87634 | 1.2% | 15 | $928.80 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.0% | 40 | $818.00 |
| 99173 | <1% | 29 | $644.38 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 62 | $636.74 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 26 | $477.10 |
| 83655 | <1% | 18 | $192.24 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 12 | $82.20 |
| 85018 | <1% | 28 | $58.52 | |
| 99177 | <1% | 13 | $48.36 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.